FPSUF (Capha Pharmaceuticals) Interest Expense: $0.00 Mil (TTM As of Jun. 2025)


What is Capha Pharmaceuticals Interest Expense?

Capha Pharmaceuticals FPSUF Interest Expense is $0.00 Mil as of Jun. 2025.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Capha Pharmaceuticals's interest expense for the three months ended in Jun. 2025 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Capha Pharmaceuticals's Operating Income for the three months ended in Jun. 2025 was $ -0.01 Mil. Capha Pharmaceuticals's Interest Expense for the three months ended in Jun. 2025 was $ 0.00 Mil. Capha Pharmaceuticals has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Capha Pharmaceuticals  (OTCPK:FPSUF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Capha Pharmaceuticals's Interest Expense for the three months ended in Jun. 2025 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2025 was $-0.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2025 was $0.00 Mil.

Capha Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2025 is calculated as

Capha Pharmaceuticals had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Capha Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Capha Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capha Pharmaceuticals Interest Expense Chart

Capha Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Capha Pharmaceuticals Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Capha Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $0.00 Mil mean?
Capha Pharmaceuticals (FPSUF) has a Interest Expense of $0.00 Mil as of Jun. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Capha Pharmaceuticals and its competitors.
Is Capha Pharmaceuticals' Interest Expense too high?
Capha Pharmaceuticals' current Interest Expense is $0.00 Mil.
How does Capha Pharmaceuticals' Interest Expense compare to GRYN and TAUG?
Capha Pharmaceuticals' Interest Expense of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Capha Pharmaceuticals and its competitors. Capha Pharmaceuticals's current Interest Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capha Pharmaceuticals stock overvalued right now?
Capha Pharmaceuticals (FPSUF) has a current Interest Expense of $0.00 Mil. The current Interest Expense is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Capha Pharmaceuticals (FPSUF), the current Interest Expense is $0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Capha Pharmaceuticals Business Description

Address 4205 Gellatly Road, Suite 324, West Kelowna, BC, CAN, V4T 2K2
Capha Pharmaceuticals Inc is a Canada-based company principally operating in the pharmaceutical industry. The company produces and distributes products in Canada and the United States of America.